Advertisement

Topics

Co-Diagnostics, Inc. Strengthens Zika Customer Base in Caribbean Basin

07:30 EDT 24 Aug 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Sales expected upon successful performance evaluation and validation Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for ...

Other Sources for this Article

Co-Diagnostics Investor Relations
Seth Egan, 801-438-1036
s.egan@codiagnostics.com

NEXT ARTICLE

More From BioPortfolio on "Co-Diagnostics, Inc. Strengthens Zika Customer Base in Caribbean Basin"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...